creating currency Top

First, heavy! Shanghai merger and reorganization action plan announcedTrue Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;

Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.This "moderately loose" statement the day before yesterday is definitely a major positive. Yesterday, A shares opened higher and went lower, but it was still expected to be too full! The high pressure level of 3500 was superimposed, so it dropped sharply. After-hours, the national society issued a document to interpret "moderate easing", and everyone understands the signal! This is a kind of expected management, which embodies the intention of caring for the economy and the stock market.Haineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%;

Yiming Food issued a suggestive announcement on the risk of stock trading. Since November 26, 2024, the company's stock has been trading daily for 11 consecutive times, with a cumulative turnover rate of 66.9%, which is a risk of a sharp decline in the short term. At the same time, several major shareholders reduced their holdings of shares not exceeding 1% of the total share capital. As of the close of December 10, 2024, the three partnership platforms reduced their holdings by 138,200 shares today.Xinhua News Agency pointed out that the important meeting held on the 9th analyzed and studied the economic work in 2025, in which the expression of monetary policy attracted people's attention. After a lapse of more than 10 years, the change of monetary policy orientation to "moderately loose" once again reflects the supportive monetary policy stance and sends a positive signal, which will strongly boost the confidence of all parties and help China's economy recover.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.